CBR 2092

Known as: CBR-2092, CBR2092 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2013
012320082013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
There is an essential need for searching for the new compounds effective in the treatment of infections caused by multidrug… (More)
Is this relevant?
2009
2009
An in silico target prediction protocol for antitubercular (antiTB) compounds has been proposed in this work. This protocol is… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2008
2008
We present data from antimicrobial assays performed in vitro that pertain to the potential clinical utility of a novel rifamycin… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Rifamycins have proven efficacy in the treatment of persistent bacterial infections. However, the frequency with which bacteria… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2008
2008
In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: 1 Studies of the Mode of Action in Staphylococcus… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 4
Is this relevant?